ApprovalTrail

Ingredient

Polyethylene Glycol 3350

Products in Health Canada’s databases that list Polyethylene Glycol 3350 as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products
35
24 authorized now
Natural health products
0
0 active licences
Notices of Compliance
7
Products in all
35

Drug products

Authorized products first.

NameDINStatus
BI-PEGLYTE (59.55 G)Pendopharm Division Of Pharmascience Inc · Status since Jun 201002326302Marketed
CLEARLAX (100 %)Perrigo International, Inc. · Status since Jun 201102324989Marketed
COLAXOR (100 %)Mantra Pharma Inc. · Status since Jul 202602450070Marketed
COLYTE (857.69 MG)Pendopharm Division Of Pharmascience Inc · Status since Apr 201300677442Marketed
COMFILAX (100 %)CellChem Pharmaceuticals Inc. · Status since Aug 201702460297Marketed
EMOLAX (100 %)JAMP Pharma Corporation · Status since Oct 201502374137Marketed
HYDRALAX (17 G)LSL MedPlus Inc. · Status since Sep 202602473119Marketed
JAMPLYTE (238.2 G)JAMP Pharma Corporation · Status since Jun 202502378329Marketed
JAMPLYTE + BISACODYL (59.55 G)JAMP Pharma Corporation · Status since Aug 202502552612Marketed
LAX-A-DAY (100 %)Pendopharm Division Of Pharmascience Inc · Status since Dec 200802317680Marketed
LAX-A-DAY PHARMA (100 %)Pharmascience Inc. · Status since Aug 201602453193Marketed
LAXATIVE (100 %)Pharmascience Inc. · Status since Dec 202502548933Marketed
MOVIPREP (100 G)Aralez Pharmaceuticals Canada Inc. · Status since Aug 202002359499Marketed
PEG 3350 (100 %)Medisca Pharmaceutique Inc. · Status since Mar 201202358034Marketed
PEG 3350 (100 %)Angita Pharma Inc. · Status since Jan 202302520796Marketed
RELAXA (100 %)Medexus Pharmaceuticals Inc. · Status since Jan 202302346672Marketed
RESTORALAX (100 %)Bayer Inc. · Status since Jan 201702318164Marketed
CLARILAX (1 G)Pharmascience Inc. · Status since May 201702464136Approved
EMOLAX 3350 (100 %)JAMP Pharma Corporation · Status since Sep 201902492121Approved
JAMP-ELECTROPEG (236.0 G)JAMP Pharma Corporation · Status since May 201302406780Approved
JAMP-ELECTROPEG WITH FLAVOUR PACKET (236.0 G)JAMP Pharma Corporation · Status since May 201302406799Approved
JAMPLYTE (59.55 G)JAMP Pharma Corporation · Status since May 201102368234Approved
POLYETHYLENE GLYCOL 3350 (100 %)Angita Pharma Inc. · Status since Mar 202102513390Approved
RIVA-LAX (17 G)Laboratoire Riva Inc. · Status since Oct 202102520885Approved
ELECTROPEG SOLUTION (238.8 G)Technilab Pharma Inc. · Status since Sep 199902230825Cancelled Post Market
KLEAN-PREP (59.00 G)Pendopharm Division Of Pharmascience Inc · Status since Jun 201702147793Cancelled Post Market
LAX-A-DAY MEN (100 %)Pendopharm Division Of Pharmascience Inc · Status since Jul 202102455617Cancelled Post Market
LAX-RELIEF (100 %)Pharmascience Inc. · Status since Jun 201902463970Cancelled Pre Market
LAXACLEAR (100 %)Perrigo International, Inc. · Status since Mar 202402391007Cancelled Pre Market
LYTEPREP (236 G)Therapex Division De E-Z-Em Canada Inc · Status since Sep 200502239569Cancelled Post Market
PEGALAX (100 %)Aralez Pharmaceuticals Canada Inc. · Status since Aug 202302328232Cancelled Post Market
PLENVU (140 G)Bausch Health, Canada Inc. · Status since Jul 202602550938Cancelled Pre Market
POLYLAX (100 %)Seaford Pharmaceuticals Inc. · Status since Jun 201602330326Cancelled Post Market
PROLAX - PWS (14.75 G)Rivex Pharma Inc. · Status since Oct 200702147785Cancelled Post Market
PURELAX (100 %)Perrigo International, Inc. · Status since Jun 201802415054Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.